ICU SeaStar Medical Holding Corporation
Company Analysis
Latest News
π’ SeaStar Medical is trading 5% up today amid market rally after weak jobs data
SeaStar Medical is trading at $3.95, up 5.33%, with broader market strength a possible contributor. - No clear company-specific catalyst was identified....
π΄ SeaStar Medical is trading at 5.6% down
SeaStar Medical is trading 5.6% lower at $3.72, with no clear company-specific news identified to explain the decline. - New ICD-10-PCS codes for its acute...
π’ SeaStar Medical is trading 10.11% up today as cooler inflation bolsters risk appetite
SeaStar Medical is trading at $3.92, up +10.11%, as broader market sentiment supports risk appetite. - The S&P 500 and Nasdaq are higher, with cooler...
π’ SeaStar Medical is trading 5.6% up with no clear company-specific catalyst identified
SeaStar Medical is trading 5.6% up at $3.76 on September 30, 2026, with no clear company-specific catalyst identified. - The broader market is higher, with the...
π’ SeaStar Medical is trading 7.6% up with no clear catalyst identified
SeaStar Medical is trading 7.6% up at $3.67, with no clear company-specific catalyst identified for the September 29, 2026 move. - The company announced that...
π΄ SeaStar Medical is trading 6.09% down today as Nasdaq-led selloff appears to explain decline
SeaStar Medical is trading 6.09% down at $3.31, with the broader Nasdaq-led selloff appearing to be the strongest available explanation amid elevated Treasury...
π΄ SeaStar Medical is trading 5% down in pre-market; catalyst remains unclear
SeaStar Medical is trading 5.29% down at $3.35 in pre-market, based on the provided price, following a $3.54 close on September 18, 2026; no clear catalyst was...
π’ SeaStar Medical is trading 5% up today; immediate catalyst remains unclear
SeaStar Medical is trading at $3.66, +5.17%, with no clear company-specific announcement identified for September 18, 2026. - Its latest official release...
π’ SeaStar Medical is trading 10.1% up today as markets recover after Federal Reserve rate decision
SeaStar Medical is trading at $3.39, up +10.06% (10.1%), with a broad market recovery after the Federal Reserveβs September 16 rate decision the most likely...
π’ SeaStar Medical is trading 5.5% up today amid a broad market rally
SeaStar Medical is trading at $3.25, up 5.5% (+5.52%), most likely alongside a strong broader-market recovery on September 17, 2026. - The S&P 500, Nasdaq...
π΄ SeaStar Medical is trading 5.2% down today despite broad U.S. market gains
SeaStar Medical is trading 5.2% down at $2.97 despite broad U.S. market gains on September 11, 2026; the reason remains unclear. - The HC Wainwright...
π’ SeaStar Medical is trading 6.13% up today with no clear catalyst identified
SeaStar Medical is trading 6.13% up at $3.29, with no clear company-specific catalyst identified for September 10, 2026. - The latest investor-relations...
π’ SeaStar Medical is trading 6.78% up today
SeaStar Medical is trading 6.78% up now at $3.15, with the immediate cause unclear. - No clear company-specific announcement, filing, FDA update, or other...
π’ SeaStar Medical is trading 6.83% up in after-hours trading with no company-specific catalyst identified
SeaStar Medical is trading at $3.08 (+6.83%) in after-hours trading, with no company-specific catalyst identified. - No September 2, 2026 company...
π΄ SeaStar Medical is trading 5% down today as rising oil prices pressured U.S. equities
SeaStar Medical is trading 5.1% down now at $2.96 after broader risk-off sentiment pressured U.S. equities on September 1, 2026. - Rising oil prices, Middle...
Investor Centre (ASX:ICU) faces ASX delisting, failing to lodge financial reports
Investor Centre Limited (ASX:ICU) remains suspended from the Australian Securities Exchange as of August 24, 2026. The ASX initially halted trading of the...
π΄ SeaStar Medical is trading 5.27% down in pre-market β catalyst remains unclear
SeaStar Medical is trading at $3.16, down 5.27%, with the catalyst unclear as of 7:18 AM EST on August 21, 2026. - No new company-specific announcement dated...
SeaStar Medical's Revenue Doubles But Cash Burns Fast β Can a Tiny Medtech Survive Long Enough to Prove Its Device Works?
Shares of SeaStar Medical (ICU) slid 7.4% to $3.11 on August 13 after the company posted second-quarter results that told two competing stories: rapid revenue...
π΄ SeaStar Medical is trading 7.4% down in pre-market after mixed second-quarter results
SeaStar Medical is trading down 7.4% now at $3.11 after mixed second-quarter results. - Revenue reached $615,000, increasing 82% year over year, while the...
SeaStar Medicalβs second quarter 2026 revenue beat estimates as pediatric QUELIMMUNE sales surged 82% YoY
SeaStar Medical reported second quarter 2026 revenue of $0.6 million, exceeding analyst expectations of $0.49 million, driven by the expanding commercial...